COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,903 Articles (22,568 medRxiv, 8,335 bioRxiv)

Most recent first Previous |  Page 1955: Articles 19541-19550  | Next

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., Pascal, K., Maurus, D., Brachtendorf, S., Loerks, V. L., Sikorski, J., Koch, P., Hilker, R., Becker, D., Eller, A.-K., Gruetzner, J., Tonigold, M., Boesler, C., Rosenbaum, C., Heesen, L., Kuehnle, M.-C., Poran, A., Dong, J. Z., Luxemburger, U., Kemmer-Brueck, A., Langer, D., Bexon, M., Bolte, S., Palanche, T., Schultz, A., Baumann, S., Mahiny, A. J., Boros, G., Reinholz, J., Szabo, G. T., Kariko, K., Shi, P.-Y., Fontes-Garfias, C., Perez, J. L., Cutler, M., Cooper, D., Kyratsous, C. A., Dormitzer, P. R., Jansen, K. U., Tuereci, O.
10.1101/2020.12.09.20245175 — Posted: 2020-12-11 Discussion: Onsite | Offsite
Impact of Convalescent Plasma Transfusion (CCP) In Patients With Previous Circulating Neutralizing Antibodies (nAb) to COVID-19
Yokoyama, A. P. H., Wendel, S., Bonet-Bub, C., Fachini, R. M., Dametto, A. P. F., Blumm, F., Dutra, V. F., Candelaria, G., Sakashita, A. M., Machado, R. R. G., Fontao-Wendel, R., Hamerschlak, N., Achkar, R., Assuncao, M., Scuracchio, P., Nudelman, V., Pastore, L., Pinho, J. R. R., Dal Ben, M., Kalil Filho, R., Marra, A. R., Amano, M. T., Kallas, E., Helito, A. S., Carvalho, C. R. R., Araujo, D. B., Durigon, E. L., Camargo, A. A., Rizzo, L. V., Reis, L. F. L., Kutner, J. M.
10.1101/2020.12.08.20246173 — Posted: 2020-12-11
The impact of the COVID-19 pandemic on college students' health and financial stability in New York City: Findings from a population-based sample of City University of New York (CUNY) students
Jones, H. E., Manze, M., Ngo, V., Lamberson, P., Freudenberg, N.
10.1101/2020.12.08.20246074 — Posted: 2020-12-11
Multimodal Data Acquisition at SARS-CoV-2 Drive Through Screening Centers: Setup Description and Experiences in Saarland, Germany
Flotho, P., Bhamborae, M., Grun, T., Trenado, C., Thinnes, D., Limbach, D., Strauss, D. J.
10.1101/2020.12.08.20240382 — Posted: 2020-12-11
Trends of COVID-19(Coronavirus Disease)in GCC Countries using SEIR-PAD Dynamic Model
Sedaghat, a., Oloomi, S. A. A., Malayer, M. A., MOSAVI, A.
10.1101/2020.11.29.20240515 — Posted: 2020-12-11
Bayesian back-calculation and nowcasting for line list data during the COVID-19 pandemic
Li, T., White, L. F.
10.1101/2020.12.08.20238154 — Posted: 2020-12-11
Antibody landscape against SARS-CoV-2 proteome revealed significant differences between non-structural/ accessory proteins and structural proteins
Li, Y., Xu, Z., Lei, Q., Lai, D., Hou, H., Jiang, H., Zheng, y., Wang, X., Wu, J., Ma, M., Zhang, B., Chen, H., Yu, C., Xue, J., Zhang, N., Qi, H., Guo, S., Zhang, Y., Lin, X., Yao, Z., Sheng, H., Sun, Z., Wang, F., Fan, X., Tao, S.-c.
10.1101/2020.12.08.20246314 — Posted: 2020-12-11
The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, India
Babu, G. R., Sundaresan, R., Athreya, S., Akhtar, J., Pandey, P. K., Maroor, P. S., MR, P., R, L., Shariff, M., Krishnappa, L., Manjunath, C., Sudarshan, M., G, G., TS, R., DE, V. K., Banandur, P., R, D., Shiju, S., Lobo, E., Satapathy, A., Alahari, L., Prameela, , T, V., Desai, A., Ravi, V.
10.1101/2020.12.04.20243949 — Posted: 2020-12-11 Discussion: Onsite
AYUSH medicine as add-on therapy for mild category COVID-19; an open label randomised, controlled clinical trial.
Rao, A., R, R., G, V., C, S., Ruthra, M., Manichen, S., SIGAMANI, A., Reddy, R. k.
10.1101/2020.12.06.20245019 — Posted: 2020-12-11
Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion
Kemp, S. A., Collier, D. A., Datir, R., Gayed, S., Jahun, A., Hosmillo, M., Ferreira, I. A., Rees-Spear, C., Mlcochova, P., Lumb, I. U., Roberts, D., Chandra, A., Temperton, N., Sharrocks, K., Blane, E., Briggs, J. A., The COVID-19 Genomics UK (COG-UK) Consortium, , The CITIID-NIHR BioResource COVID-19 Collaboration, , Smith, K. G., Bradley, J. R., Smith, C., Goldstein, R., Goodfellow, I. G., Smielewska, A., Skittrall, J. P., Gouliouris, T., Gkrania-Klotsas, E., Illingworth, C. J., McCoy, L. E., Gupta, R. K.
10.1101/2020.12.05.20241927 — Posted: 2020-12-11 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).